BIO15PHARMA : Pharmaceutical Interim Management and GxP Compliance From a Single Partner

Most life sciences companies call on three different kinds of provider when quality or compliance is at stake: a consultancy to diagnose the problem, an interim management firm to bring in the right people, and a software vendor to supply the tools. BIO15PHARMA does all three. This French firm pairs a network of senior quality and regulatory experts with its own digital solutions, then puts both to work on site, within 24 hours, anywhere in the world. That hybrid model is rare in pharmaceutical interim management and GxP compliance. The expertise is hard to find. The solutions are built in-house. And a single partner stays accountable from the first diagnosis to the final result.

A sector where a compliance gap stops everything : Since 2015, regulators including the ANSM and the FDA have issued a steady stream of injunctions across the life sciences. The cause is almost always the same: a failing quality management system, or a serious breach of Good Manufacturing Practices. The effects are immediate. Production halts, batches stay blocked, certification stalls, and products never reach the market. These pressures go well beyond pharmaceuticals. Chemical manufacturers, cosmetics producers, medical device makers, biotech companies, CROs and healthcare facilities all answer to the same GxP standards and the same inspections. For any of them, a quality crisis is a business continuity problem first.

Expertise you can deploy in 24 hours : BIO15PHARMA was founded in Rouen in 2021 by Nadjim Mhoma, after 14 years in quality and regulatory roles across big pharma. His reason for building the firm is personal: he lost his father to a shortage of insulin, and has devoted his career to the quality and supply of medicines so that other patients are not failed the same way. That conviction, keeping the patient at the center of every process, still runs through the company.

Behind it stands a network of more than 3,600 independent experts, each with at least 10 years in the life sciences. They are responsible pharmacists, quality and quality control directors, regulatory affairs and pharmacovigilance directors, GMP auditors, and former inspectors, some of whom have carried out more than 500 inspections for the ANSM. They mobilize within 24 hours, internationally, and never work a mission alone.

Innovation that reduces compliance risk : What makes the 24-hour promise credible is what the experts bring with them. BIO15PHARMA has developed its own tools and deploys them directly inside client operations: electronic document management for a paperless, audit-ready quality system, electronic batch records, and platforms that run inspections and audits remotely. Its cleanroom bio-decontamination method gave one pharmaceutical client back 22 days of production a year. The same teams handle the work that keeps regulators satisfied: GxP compliance projects, data integrity, simplified process mapping with ICH Q9 risk analysis, and staff training and certification. For companies entering regulated markets, the firm sets up new pharmaceutical subsidiaries from end to end, from the establishment authorization dossier and the marketing authorization through to the GMP fundamentals and the quality system itself.

Proven where it matters most : BIO15PHARMA has lifted 21 regulatory injunctions, allowing clients to resume producing, certifying, releasing and selling. Its references include Sanofi, GSK, Novartis, Servier, Clarins, Hermès, Guerbet and Aguettant. The firm belongs to LEEM, the French pharmaceutical industry association, and its founder was named Executive Manager of the Year at the 2022 Reactive Business Awards. He is also a certified quality, safety and environmental auditor, with ISO 9001, 14001 and OHSAS 18001 projects to his name.

A partner for life sciences, wherever you operate : Six values guide BIO15PHARMA's work: trust between partners, employee commitment, patient safety, team accountability, simpler processes, and results that hold up. An unannounced inspection, an audit finding, the sudden loss of a key quality lead, the build-out of a new site: these are the moments the firm is built for, with the people and tools to resolve them.